Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents by Jessica Castro, Marc Ribó, Maria Vilanova, Antoni Benito

Connect to this object online.

Cerebroprotective Effects of the TLR4-Binding DNA Aptamer ApTOLL in a Rat Model of Ischemic Stroke and Thrombectomy Recanalization by Alicia Aliena-Valero, Macarena Hernández-Jiménez, Mikahela A. López-Morales, Eva Tamayo-Torres, María Castelló-Ruiz, David Piñeiro, Marc Ribó, Juan B. Salom

Connect to this object online.

Added value of patient-reported outcome measures (PROMs) after an acute stroke and early predictors of 90 days PROMs by Ester Sanchez-Gavilan, Estefania Montiel, Maria Baladas, Sofia Lallanas, Eva Aurin, Carolina Watson, Maria Gutierrez, Yolima Cossio, Marc Ribo, Carlos A. Molina, Marta Rubiera

Connect to this object online.

First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers by Macarena Hernández-Jiménez, Samuel Martín-Vílchez, Dolores Ochoa, Gina Mejía-Abril, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Bernd Jilma, María A. Moro, Gerónimo Fernández, David Piñeiro, Marc Ribó, Víctor M. González, Ignacio Lizasoain, Francisco Abad-Santos

Connect to this object online.